| pubmed-article:21514523 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C0005767 | lld:lifeskim |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C0796679 | lld:lifeskim |
| pubmed-article:21514523 | lifeskim:mentions | umls-concept:C1519810 | lld:lifeskim |
| pubmed-article:21514523 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21514523 | pubmed:dateCreated | 2011-4-25 | lld:pubmed |
| pubmed-article:21514523 | pubmed:abstractText | To evaluate whether the neutrophil-to-lymphocyte ratio (NLR) predicts survival in patients with unresectable hepatocellular carcinoma (HCC) before and after transarterial chemoembolization treatment. | lld:pubmed |
| pubmed-article:21514523 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21514523 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21514523 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21514523 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21514523 | pubmed:month | May | lld:pubmed |
| pubmed-article:21514523 | pubmed:issn | 1535-7732 | lld:pubmed |
| pubmed-article:21514523 | pubmed:author | pubmed-author:NellL JLJ | lld:pubmed |
| pubmed-article:21514523 | pubmed:author | pubmed-author:PaiR KRK | lld:pubmed |
| pubmed-article:21514523 | pubmed:author | pubmed-author:ChenMin-ShanM... | lld:pubmed |
| pubmed-article:21514523 | pubmed:author | pubmed-author:LiJin-QingJQ | lld:pubmed |
| pubmed-article:21514523 | pubmed:author | pubmed-author:HuangZhi-Lian... | lld:pubmed |
| pubmed-article:21514523 | pubmed:copyrightInfo | Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:21514523 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21514523 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:21514523 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21514523 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21514523 | pubmed:pagination | 702-9 | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:meshHeading | pubmed-meshheading:21514523... | lld:pubmed |
| pubmed-article:21514523 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21514523 | pubmed:articleTitle | Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization. | lld:pubmed |
| pubmed-article:21514523 | pubmed:affiliation | Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, PR China. | lld:pubmed |
| pubmed-article:21514523 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21514523 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
